Kyongsik Yun received a BS (2006) and a PhD (2010) in brain engineering at the Korea Advanced Institute of Science and Technology (KAIST). Yun then moved to the California Institute of Technology (Caltech), where he published two innovative Nature papers on artificial telepathy and noninvasive neural network modulation. Yun co-founded two biotech companies, Ybrain (2012) and BBB (2015) that raised $9.8M. He continues working on developing novel technologies for the early diagnostics and the treatment of brain disorders. Yun’s pioneering technology has far-reaching implications for the future of human brain health. It is set to play an integral role in the treatment of brain disorders such as Parkinson’s disease, autism and psychiatric illnesses. He believes that this safe, effective and mobile technology will revolutionize brain science and the medical industry.
Did you know?

Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.

To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.

In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.

The question for Sumit Sinha and Mukesh Bansal in February 2019 was which would come first: The funding for their seed round or the sale of their Hyundai hatchbacks.

In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.

It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.

Tesh Mbaabu rarely showed up to his freshman computer science class at the University of Nairobi. His classmate Mesongo Sibuti noticed.

Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.